Обозреватель Глобального фонда

Обозреватель Глобального фонда является ведущим независимым изданием, которое  предоставляетинформацию, анализ и делится мнениями о Глобальном фонде. Для получения авторитетных и заслуживающих доверия разъяснений о политике, практике и процедурах Секретариата, а также инсайдерской информации о заседаниях Правления Глобального фонда и знакомства с реальными историями, касающимися воздействия и роли Глобального фонда на страновом уровне, подпишитесь на наш бесплатный новостной бюллетень, выходящий два раза в месяц.

Чтобы ваша почтовая система не рассматривала рассылку  Обозревателя Глобального фонда как спам, следует добавить  gfo-newsletter@aidspan.org в ваш список адресов, с которых разрешено принимать почту.  Если вы не знаете, как это сделать, свяжитесь с вашим системным администратором или службой технической поддержки.

Последняя статья в ОГФ в прямом эфире



At the 22nd International AIDS Conference in Amsterdam, the global community recognized that reaching UNAIDS’ Fast Track ‘90-90-90’ targets by 2020, or even 2030, is unlikely to happen. At the same time, experts called for “common cause” with the global health agenda, saying that without integrated programs the attainment of Universal Health Care and increased momentum in the fight against HIV are unlikely.


The Global Fund’s Executive Director spelled out plainly, in different sessions at the International AIDS Conference in Amsterdam, the need for the governments of implementing countries, and the private sector, to step up their contributions to the HIV response – and towards reaching UHC. He also advocated for an increase in global health’s share of development assistance. 


The Global Fund’s six regional Community, Rights and Gender (CRG) platforms came together at the 22nd  International AIDS Conference (AIDS 2018) to host the Global Fund Community Zone in the Global Village. The networking zone provided space for AIDS 2018 participants in Amsterdam to connect with each of the regional platforms, learn about key areas of work under the Global Fund CRG Strategic Initiative, engage with community partners that receive support from the Global Fund and discuss relevant issues to civil society and community groups. The Community Zone also hosted a townhall meeting with Executive Director Peter Sands.


With broad acknowledgement at AIDS2018 in Amsterdam that development assistance for HIV is in decline, funding discussions turned to the need for increased funding from implementing countries’ own domestic sources. Here South African health economist Alan Whiteside explains his view on the tricky situation of middle-income countries with high HIV burdens.


Findings from four studies on combination prevention for adolescents in Malawi, South Africa, Zambia and Tanzania funded by the EHPSA programme suggest that youth-friendly and appropriate services are the key to HIV prevention in eastern and southern Africa. The research showed that non-judgemental attitudes from kindly health workers are often the deciding factor for uptake and retention in care.


A delegation of East Africans visited harm reduction facilities in China to learn about their approach take-home methadone for people who use drugs, for possible application at home. The exchange was organized via the Global Fund’s multi-country harm reduction grant in East Africa, which is coming to an end this year.


At its last Board Meeting, the Global Fund opened a formal consultation process to develop a more structured approach to innovative finance within the organization. The Global Fund is considering several different approaches to innovative finance, many of which would require a change in organizational policy and the way that it interacts with its partners and the countries it services. The Global Fund Observer takes a closer look at different innovative financing instruments over a series of three articles. This first article describes the background and rationale for the change in policy and discusses the pros and cons of development cooperation mechanisms, such as debt swaps and blended finance. 


This study from the Kaiser Family Foundation and UNAIDS finds donor government funding for HIV rose to US$8.1 billion in 2017, from $7 billion in 2016, due to a shift in the timing of U.S. disbursements. This would appear to contradict recent reports of a 'flat-lining' of donor funding for the HIV response, but the study says this boost included funds appropriated but not spent from previous years.